First Dallas Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $876K | Sell |
4,027
-12,199
| -75% | -$2.71M | 0.32% | 66 |
|
|
2025
Q4 | $3.71M | Sell |
16,226
-146
| -0.9% | -$33.3K | 1.38% | 18 |
|
|
2025
Q3 | $3.79M | Sell |
16,372
-321
| -2% | -$65.4K | 1.42% | 17 |
|
|
2025
Q2 | $3.1M | Sell |
16,693
-860
| -5% | -$160K | 1.22% | 23 |
|
|
2025
Q1 | $3.68M | Sell |
17,553
-716
| -4% | -$139K | 1.54% | 12 |
|
|
2024
Q4 | $3.25M | Buy |
18,269
+644
| +4% | +$118K | 1.32% | 21 |
|
|
2024
Q3 | $3.48M | Sell |
17,625
-955
| -5% | -$178K | 1.45% | 17 |
|
|
2024
Q2 | $3.19M | Sell |
18,580
-295
| -2% | -$48.9K | 1.4% | 15 |
|
|
2024
Q1 | $3.44M | Sell |
18,875
-1,101
| -6% | -$190K | 1.58% | 13 |
|
|
2023
Q4 | $3.1M | Buy |
19,976
+12,528
| +168% | +$1.83M | 1.6% | 13 |
|
|
2023
Q3 | $1.11M | Sell |
7,448
-14,975
| -67% | -$2.2M | 0.25% | 89 |
|
|
2023
Q2 | $3.02M | Sell |
22,423
-4,402
| -16% | -$646K | 1.69% | 12 |
|
|
2023
Q1 | $4.28M | Buy |
26,825
+277
| +1% | +$42.3K | 2.52% | 5 |
|
|
2022
Q4 | $4.29M | Buy |
26,548
+448
| +2% | +$68.7K | 2.59% | 4 |
|
|
2022
Q3 | $3.51M | Sell |
26,100
-417
| -2% | -$59.8K | 2.41% | 6 |
|
|
2022
Q2 | $4.06M | Sell |
26,517
-3,087
| -10% | -$472K | 2.74% | 5 |
|
|
2022
Q1 | $4.8M | Sell |
29,604
-1,581
| -5% | -$230K | 2.71% | 5 |
|
|
2021
Q4 | $4.22M | Sell |
31,185
-145
| -0.5% | -$17.1K | 2.77% | 5 |
|
|
2021
Q3 | $3.38M | Buy |
31,330
+505
| +2% | +$57.7K | 2.33% | 6 |
|
|
2021
Q2 | $3.47M | Sell |
30,825
-145
| -0.5% | -$16.3K | 2.28% | 7 |
|
|
2021
Q1 | $3.35M | Sell |
30,970
-194
| -0.6% | -$20.8K | 2.85% | 4 |
|
|
2020
Q4 | $3.34M | Buy |
31,164
+327
| +1% | +$31.4K | 3.01% | 4 |
|
|
2020
Q3 | $2.7M | Buy |
+30,837
| New | +$2.9M | 3.04% | 8 |
|
|
2020
Q1 | $1.9M | Buy |
24,931
+354
| +1% | +$30.2K | 2.65% | 11 |
|
|
2019
Q4 | $2.18M | Buy |
24,577
+304
| +1% | +$25.2K | 1.86% | 18 |
|
|
2019
Q3 | $1.84M | Buy |
24,273
+4,815
| +25% | +$330K | 1.63% | 18 |
|
|
2019
Q2 | $1.42M | Buy |
19,458
+280
| +1% | +$22K | 1.24% | 24 |
|
|
2019
Q1 | $1.55M | Sell |
19,178
-6,531
| -25% | -$534K | 1.11% | 26 |
|
|
2018
Q4 | $2.37M | Sell |
25,709
-1,055
| -4% | -$92.8K | 1.98% | 13 |
|
|
2018
Q3 | $2.53M | Sell |
26,764
-47
| -0.2% | -$4.46K | 1.58% | 17 |
|
|
2018
Q2 | $2.48M | Buy |
26,811
+198
| +0.7% | +$19.3K | 1.59% | 14 |
|
|
2018
Q1 | $2.52M | Sell |
26,613
-229
| -0.9% | -$25.2K | 1.64% | 13 |
|
|
2017
Q4 | $2.6M | Sell |
26,842
-348
| -1% | -$32.8K | 1.65% | 15 |
|
|
2017
Q3 | $2.42M | Sell |
27,190
-5,092
| -16% | -$388K | 1.67% | 15 |
|
|
2017
Q2 | $2.34M | Sell |
32,282
-4,098
| -11% | -$276K | 1.71% | 15 |
|
|
2017
Q1 | $2.37M | Buy |
36,380
+7,504
| +26% | +$472K | 1.65% | 18 |
|
|
2016
Q4 | $1.81M | Buy |
28,876
+11,521
| +66% | +$703K | 1.24% | 22 |
|
|
2016
Q3 | $1.09M | Buy |
17,355
+9,150
| +112% | +$592K | 0.81% | 31 |
|
|
2016
Q2 | $508K | Buy |
8,205
+3,550
| +76% | +$216K | 0.39% | 54 |
|
|
2016
Q1 | $266K | Buy |
4,655
+50
| +1% | +$2.79K | 0.22% | 82 |
|
|
2015
Q4 | $273K | Buy |
4,605
+750
| +19% | +$43.2K | 0.22% | 77 |
|
|
2015
Q3 | $210K | Buy |
3,855
+525
| +16% | +$34.2K | 0.17% | 88 |
|
|
2015
Q2 | $224K | Buy |
+3,330
| New | +$217K | 0.16% | 92 |
|
Other funds holding ABBV
VCM
VPM
First Dallas Securities's ABBV Position: Q1 2026 in Review
First Dallas Securities reduced its AbbVie (ABBV) stake by 75% in Q1 2026, selling an estimated $2.71M and leaving 4,027 shares worth $876K. The position accounts for 0.32% of the portfolio, ranked #66.
First Dallas Securities first reported a position in ABBV in Q2 2015 and has held it in 43 quarters since. The position peaked at $4.8M in Q1 2022. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- First Dallas Securities held 4,027 shares of AbbVie worth $876K as of Q1 2026.
- First Dallas Securities sold 12,199 AbbVie shares in Q1 2026, an estimated $2.71M.
- AbbVie made up 0.32% of First Dallas Securities's portfolio in Q1 2026, its #66 holding.
- First Dallas Securities first reported a position in AbbVie in Q2 2015 and has held it in 43 quarters since.
- First Dallas Securities's AbbVie position peaked at $4.8M in Q1 2022.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on First Dallas Securities's 13F filing for Q1 2026, filed 27 Apr 2026.